Hemophilia therapy: the future has begun

医学
作者
Pier Mannuccio Mannucci
出处
期刊:Haematologica [Ferrata Storti Foundation]
卷期号:105 (3): 545-553 被引量:251
标识
DOI:10.3324/haematol.2019.232132
摘要

The success story of hemophilia care first began in the 1970s, when the availability of plasma-derived concentrates of coagulation factor VIII (FVIII) and factor IX (FIX) provided efficacious treatment of bleeding in patients with hemophilia A and B. This positive scenario was consolidated in terms of greater safety and availability in the 1990s, when the first recombinant coagulation factors were produced. This meant that, instead of only treating episodic bleeding events, prophylaxis regimens could be implemented as a preventive measure. Following the demonstration of its superiority in the frame of two randomized clinical trials, prophylaxis became evidence-based standard of care. In high-income countries, these achievements have led to a patients' life expectancy being extended to close to that of the general male population. Alongside this, the last decade has witnessed further spectacular therapeutic progress, such as the availability of coagulation factors with a longer plasma half-life that allow for wider intervals between treatment. Moreover, new therapeutic products based on new mechanisms other than the replacement of the deficient factor, have become available (emicizumab) or are at an advanced stage of development. This review celebrates the success story of hemophilia care, while also discussing current limitations, issues and as yet unmet needs. The prospects of cure by means of gene therapy are also outlined.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
斯文败类的应助被着急的依波采纳,获得30
刚刚
1秒前
1秒前
青柠完成签到 ,获得积分10
2秒前
2秒前
斯文败类的应助被倾慕采纳,获得10
3秒前
molihuakai的应助被元旦采纳,获得10
4秒前
李垚发布了新的文献求助10
4秒前
瓢闻馅发布了新的文献求助10
5秒前
无极微光的应助被李半斤采纳,获得20
5秒前
ysgzg20123完成签到,获得积分10
5秒前
yao完成签到,获得积分10
6秒前
6秒前
6秒前
科研通AI2S的应助被咻咻咻采纳,获得10
6秒前
Maestro_S的应助被yh采纳,获得10
6秒前
安安完成签到 ,获得积分10
6秒前
科研通AI6.3的应助被yh采纳,获得10
7秒前
7秒前
pkfsp发布了新的文献求助10
8秒前
z66完成签到,获得积分10
8秒前
可爱的蓝天完成签到 ,获得积分10
8秒前
9秒前
9秒前
Noreason完成签到 ,获得积分10
9秒前
顾矜的应助被51515采纳,获得10
10秒前
10秒前
wenlin完成签到,获得积分10
11秒前
西大可怜虫完成签到,获得积分10
11秒前
12秒前
xixi发布了新的文献求助10
12秒前
wyp给张临秋的求助进行了留言
13秒前
香蕉觅云的应助被Bai采纳,获得10
13秒前
keggin发布了新的文献求助10
13秒前
14秒前
捡破烂的发布了新的文献求助10
15秒前
15秒前
天天快乐的应助被粗暴的依波采纳,获得20
16秒前
zrl完成签到,获得积分20
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178695
求助须知:如何正确求助?哪些是违规求助? 9569449
关于积分的说明 21804643
捐赠科研通 7773744
什么是DOI,文献DOI怎么找? 3432903
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478500